Caplin Point Laboratories Ltd Financials

Market Capitalization ₹166.86 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	33.90
Forward PE	28.09
Price to Sales TTM	₹9.10
Price to Book MRQ	₹6.76
Enterprise to Revenue	8.77
Enterprise to EBITDA	26.63

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2024-03-31
Most Recent Quarter	2024-09-30
Profit Margin	26.93%
Operating Margin	30.64%
Return on Assets TTM	12.74%
Return on Equity TTM	21.24%

Income Statement

Revenue TTM	₹18,327,900,160
Revenue per Share TTM	₹241.31
Quarterly Revenue Growth	17.80%
Gross Profit TTM	₹10,450,599,936
EBITDA	₹6,756,300,000
Net Income to Common TTM	₹4,935,600,128
Diluted EPS TTM	₹64.75
Quarterly Earnings Growth YoY	13.90%

Balance Sheet

Total Cash MRQ	₹8,266,200,064
Total Cash per Share MRQ	₹108.83
Total Debt MRQ	₹
Total Debt to Equity MRQ	0.09
Current Ratio MRQ	6.07
Book Value per Share MRQ	₹324.91

Cash Flow

Operating Cash Flow TTM	₹3,747,800,064
Levered Free Cash Flow TTM	₹1,072,512,512

CAPLIPOINT Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	76,011,696
Float Shares	19,297,178
Avg 10 Volume	134,715
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	73.27%
% Held by Institutions	3.70%

Stock Price Summary

Beta	0.40
Fifty Two Week Low	₹1225.00
Fifty Two Week High	₹2641.00
Fifty Two Week Change	33.81%
Day 50 MA	₹2295.44
Day 200 MA	₹1787.19

Dividends and Splits

Forward Annual Dividend Rate	₹5.00
Forward Annual Dividend Yield	0.23%
Trailing Annual Dividend Rate	₹5.00
Trailing Annual Dividend Yield	0.23%
Payout Ratio	7.73%
Dividend Date
Ex Dividend Date	2024-09-23
Last Split Factor
Last Split Date	2016-10-19